Product Information

GLIPIZIDE ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1226 per EA under NDC 64980028101. Its NADAC has been published 472 times since Aug 9, 2017.

FDA first approved this application on Dec 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE ER 10 MG TABLET

Glipizide
$0.1226per EA

Strength

10 mg/1

NDC

64980028101

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GLIPIZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204720

FDA Approved

12/29/2016

TE Code

AB

On Market Since

4/24/2017

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE ER 10 MG TABLET has been published 472 times since Aug 9, 2017, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1226 per EA
All-time high$0.2740 (Mar 14, 2018)
All-time low$0.1226 (Aug 19, 2026)
52-week high$0.1429
52-week low$0.1226
Median price$0.1836
Average price$0.1899
Largest weekly change-20.0% (Apr 17, 2024)
Weeks tracked472
Tracking sinceAug 9, 2017

Price History

1W

-2.3%

1M

-2.3%

3M

-6.0%

6M

-8.3%

1Y

-14.2%

3Y

-36.6%

5Y

-37.8%

All

-53.2%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GLIPIZIDE ER 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1226 per EA (NDC 64980028101), effective Aug 19, 2026.

How has the price of GLIPIZIDE ER 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE ER 10 MG TABLET has declined 53.2%. It has been tracked across 472 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 10 MG TABLET?

Since Aug 9, 2017, the NADAC for GLIPIZIDE ER 10 MG TABLET has ranged from a low of $0.1226 (Aug 19, 2026) to a high of $0.2740 (Mar 14, 2018), with a median of $0.1836 per EA.

Are there cheaper alternatives to GLIPIZIDE ER 10 MG TABLET?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIPIZIDE 10 MG TABLET, is $0.0464 per EA — about 62% below GLIPIZIDE ER 10 MG TABLET.

Who manufactures GLIPIZIDE ER 10 MG TABLET?

GLIPIZIDE ER 10 MG TABLET (NDC 64980028101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.